The Boston Business Journal (Free subscription) | 02/12/2008
Genzyme Corp. (Nasdaq: GENZ) suffered a setback in Europe when its patent for plastic-based gels compatible with human tissue was revoked.
GuruFocus Updates (Free subscription) | 01/12/2008
www.OSIR.org.in (Free subscription) | 30/11/2008
Nov 4 (Reuters) - Genzyme Corp (GENZ.O: Quote , Profile , Research , Stock Buzz ) said it would co-develop and market two adult stem cell products of Osiris Therapeutics (OSIR.O: Quote , Profile , Research , Stock Buzz ) that are being tested for Source: www.reuters.com Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers [...]
Business Week (Free subscription) | yesterday
... push indexes back into positive territory. Gains in defensive issues (Coca-Cola Co. (), McDonald's Corp. ()), (Genzyme Corp. (), Gilead Sciences ()), financials (Morgan Stanley , Merrill Lynch ), retailers (JCPenney ()), and homebuilders (Toll Brothers () offset declines in commodities issues (Alcoa ()). Traders also weighed glum earnings news from Research in Motion Ltd. (),...
www.OSIR.org.in (Free subscription) | 02/12/2008
2008-11-09 23:53:01 - Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory Source: www.pr-inside.com UPDATE 1-Genzyme, Osiris to develop stem cell products - ReutersNov 4 (Reuters) - Genzyme Corp (GENZ.O:...
